[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#pubInfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#Head"
}, {
  "@graph" : [ {
    "@id" : "http://identifiers.org/drugbank/DB01267",
    "@type" : [ "https://w3id.org/biolink/vocab/Drug" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Paliperidone"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  }, {
    "@id" : "http://purl.obolibrary.org/obo/MONDO_0005090",
    "@type" : [ "https://w3id.org/biolink/vocab/Disease" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Manic bipolar affective disorder"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#association",
    "@type" : [ "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/MONDO_0005090"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "http://identifiers.org/drugbank/DB01267"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Paliperidone is FDA-approved for schizophrenia aged 12-17. However, the pharmacologic portfolio, extrapolation from adult studies, and the long track record of the parent drug, risperidone in child/adolescent psychiatric (CAP) population might expand its therapeutic potential. An 8-week open-label study [9] examined paliperidone monotherapy for acute mania, mixed, or hypomanic episode in pediatric patients (n = 15, 6–17 years of age) with bipolar spectrum disorders. At the end of follow-up period, 11 subjects (73%) completed the study; treatment with paliperidone was associated with a 60% response rate (50% decrease in the Young Mania Rating Scale) and 40% remission (YMRS <12)"
    } ],
    "https://w3id.org/biolink/vocab/aggregator_knowledge_source" : [ {
      "@id" : "https://w3id.org/biolink/infores/knowledge-collaboratory"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/has_population_context" : [ {
      "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#context"
    } ],
    "https://w3id.org/biolink/vocab/publications" : [ {
      "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/31096228"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "http://purl.obolibrary.org/obo/NCIT_C94303"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#context",
    "@type" : [ "https://w3id.org/biolink/vocab/Cohort" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Children and adolescents (6-17 years)"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Cohort"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI",
    "http://www.w3.org/ns/prov#generatedAtTime" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2022-09-16T11:50:40.267580"
    } ],
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1501-1082"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "MvwpmExq3ICFcY5B+BxMqvEkyn/L4WcUEGBvg9Ii25zQa3w/jFNhelcF/DdrqKosngpIawhpYivo17fgcaqod1wGoOgHleTBJ4T/LQeTcm6ctNvQDNGFmiht0AaftchduTGtIvRilMbSTy7pSCCxwMzXhtxU1YHX/12CM/5aQJ4="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI"
    } ]
  }, {
    "@id" : "https://w3id.org/biolink/vocab/",
    "http://purl.org/pav/version" : [ {
      "@value" : "2.3.0"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAmBxV9NwPCJF00tOcDOvIaWVPltHn-LOIupuYkqY93fI#pubInfo"
} ]